Campylobacter jejuni (Jones et al.) Veron and Chatelain (ATCC® BAA-2151)

Strain Designations: 81-176  /  Type Strain: no  /  Biosafety Level: 2

Permits And Restrictions

View Permits

Strain Designations 81-176
Application
Emerging infectious disease research
Enteric Research
Isolation
Human patient during clinical trial
By the Center for Vaccine Development (CVD)
Type Strain no
Biosafety Level 2
Product Format freeze-dried
Preceptrol® no
Genome Sequenced Strain

Campylobacter jejuni subsp. jejuni 81-176, complete genome

Type Strain no
Comments
Genome sequenced strain
Medium ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood
Growth Conditions
Temperature: 37°C
Atmosphere: Microaerophilic (3-5% O2-10% CO2)
Name of Depositor P Guerry-Kopecko
Isolation
Human patient during clinical trial
By the Center for Vaccine Development (CVD)
References

Russell RG, et al. Experimental Campylobacter jejuni infection in Macaca nemestrina. Infect. Immun. 57(5): 1438-1444, 1989. PubMed: 2707853

Cross References

Nucleotide (GenBank) : CP000538 Campylobacter jejuni subsp. jejuni 81-176, complete genome

Nucleotide (GenBank) : CP000549 Campylobacter jejuni subsp. jejuni 81-176 plasmid pTet, partial sequence

Nucleotide (GenBank) : CP000550 Campylobacter jejuni subsp. jejuni 81-176 plasmid pVir, complete sequence

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation